- Home
- SSTI vs SLS Comparison
SSTI vs SLS Comparison
Compare SSTI & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSTI
- SLS
- Stock Information
- Founded
- SSTI 1996
- SLS 2012
- Country
- SSTI United States
- SLS United States
- Employees
- SSTI N/A
- SLS N/A
- Industry
- SSTI Computer Software: Prepackaged Software
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- SSTI Technology
- SLS Health Care
- Exchange
- SSTI Nasdaq
- SLS Nasdaq
- Market Cap
- SSTI 196.6M
- SLS 169.6M
- IPO Year
- SSTI 2017
- SLS N/A
- Fundamental
- Price
- SSTI $13.69
- SLS $2.05
- Analyst Decision
- SSTI Buy
- SLS
- Analyst Count
- SSTI 8
- SLS 0
- Target Price
- SSTI $20.38
- SLS N/A
- AVG Volume (30 Days)
- SSTI 52.1K
- SLS 3.3M
- Earning Date
- SSTI 08-05-2025
- SLS 08-12-2025
- Dividend Yield
- SSTI N/A
- SLS N/A
- EPS Growth
- SSTI N/A
- SLS N/A
- EPS
- SSTI N/A
- SLS N/A
- Revenue
- SSTI $104,970,000.00
- SLS N/A
- Revenue This Year
- SSTI $11.41
- SLS N/A
- Revenue Next Year
- SSTI $8.56
- SLS N/A
- P/E Ratio
- SSTI N/A
- SLS N/A
- Revenue Growth
- SSTI 7.65
- SLS N/A
- 52 Week Low
- SSTI $9.33
- SLS $0.77
- 52 Week High
- SSTI $19.43
- SLS $2.22
- Technical
- Relative Strength Index (RSI)
- SSTI 25.79
- SLS 64.79
- Support Level
- SSTI $12.60
- SLS $1.50
- Resistance Level
- SSTI $15.80
- SLS $2.22
- Average True Range (ATR)
- SSTI 0.74
- SLS 0.15
- MACD
- SSTI -0.34
- SLS 0.05
- Stochastic Oscillator
- SSTI 14.12
- SLS 81.81
About SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.